Carbogen Amcis successfully completed Swissmedic inspection of its Vionnaz facility
The site’s GMP Certification has been successfully renewed
The site’s GMP Certification has been successfully renewed
Therapy recently approved in Canada under the brand name KORSUVA
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Subscribe To Our Newsletter & Stay Updated